医学
体外膜肺氧合
入射(几何)
置信区间
荟萃分析
呼吸机相关性肺炎
相对风险
内科学
肺炎
临床终点
重症监护
重症监护医学
临床试验
光学
物理
作者
Ali Ait Hssain,Amir Vahedian‐Azimi,Abdulsalam Saif Ibrahim,Ibrahim Fawzy Hassan,Élie Azoulay,Michaël Darmon
出处
期刊:Critical Care
[BioMed Central]
日期:2024-05-10
卷期号:28 (1)
被引量:11
标识
DOI:10.1186/s13054-024-04946-8
摘要
Abstract Background An increasing number of patients requires extracorporeal membrane oxygenation (ECMO) for life support. This supportive modality is associated with nosocomial infections (NIs). This systematic review and meta-analysis aim to assess the incidence and risk factors of NIs in adult. Methods We searched PubMed, Scopus, Web of Science, and ProQuest databases up to 2022. The primary endpoint was incidence of NI. Secondary endpoints included time to infection, source of infection, ECMO duration, Intensive care and hospital length of stay (LOS), ECMO survival and overall survival. Incidence of NI was reported as pooled proportions and 95% confidence intervals (CIs), while dichotomous outcomes were presented as risk ratios (RR) as the effective index and 95% CIs using a random-effects model. Results Among the 4,733 adult patients who received ECMO support in the 30 included studies, 1,249 ECMO-related NIs per 1000 ECMO-days was observed. The pooled incidence of NIs across 18 studies involving 3424 patients was 26% (95% CI 14–38%).Ventilator-associated pneumonia (VAP) and bloodstream infections (BSI) were the most common NI sources. Infected patients had lower ECMO survival and overall survival rates compared to non-infected patients, with risk ratio values of 0.84 (95% CI 0.74–0.96, P = 0.01) and 0.80 (95% CI 0.71–0.90, P < 0.001), respectively. Conclusion Results showed that 16% and 20% lower of ECMO survival and overall survival in patients with NI than patients without NI, respectively. However, NI increased the risk of in-hospital mortality by 37% in infected patients compared with non-infected patients. In addition, this study identified the significant positive correlation between ECMO duration and ECMO-related NI.
科研通智能强力驱动
Strongly Powered by AbleSci AI